ARCHIVES

Study Validates “PEM” Scans As Biopsy Guidance Method

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006

First Mobil NMR Scanner Goes Into Operation At Temple

June 22, 1984

In Brief: James Downing named CEO of St. Jude

June 27, 2014

First Formal CREG Guidelines, Rules Publishes

June 6, 1975

NCI’s caBIG to Expand For Clinical Informatics Projects.

January 26, 2007

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976